Is Grifols SA - ADR ADR Class B (GRFS) a Loser in the Healthcare Sector?

A rating of 25 puts Grifols SA - ADR ADR Class B (GRFS) near the top of the Healthcare sector according to InvestorsObserver. Grifols SA - ADR ADR Class B's score of 25 means that it ranks higher than 25% of stocks in the sector. In addition, its overall score of 19 ranks it higher than 19% of all stocks.

GRFS has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on GRFS!

See Full GRFS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 19 means the stock is more attractive than 19 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Grifols SA - ADR ADR Class B Stock Today?

Grifols SA - ADR ADR Class B (GRFS) stock is down -0.97% while the S&P 500 has risen 0.71% as of 3:39 PM on Monday, Mar 20. GRFS has fallen -$0.07 from the previous closing price of $6.71 on volume of 793,760 shares. Over the past year the S&P 500 is lower by -11.58% while GRFS has fallen -38.93%. GRFS earned $0.10 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 66.13. Click Here to get the full Stock Report for Grifols SA - ADR ADR Class B stock.